Skip to content

Myocardial Flow Reserve and 99mTc-DTPA Cardiac Dynamic SPECT

Feasibility of Dynamic Cardiac SPECT With 99mTc-diethylenetriaminepenta-acetate (DTPA) for the Assessment of Myocardial Flow Reserve Using a Cadmium-Zinc-Telluride (CZT) Camera

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02844686
Acronym
Flow-Heart
Enrollment
20
Registered
2016-07-26
Start date
2016-08-31
Completion date
2018-08-31
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Myocardial perfusion imaging, Single-Photon Emission Computer-Assisted Tomography

Brief summary

New CZT-based SPECT cameras are potentially capable of dynamic 3-D acquisition. Preliminary results suggested that dynamic acquisitions could allow the assessment of myocardial flow reserve using 99mTc-labelled perfusion tracers. The Flow-Heart study will assess the feasibility of myocardial flow reserve measurement by means of 99mTc-DTPA dynamic cardiac SPECT in 20 patients.

Interventions

OTHERCardiac SPECT

3-D dynamic acquisition of cardiac SPECT at rest and after pharmacological stress

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Patient clinically stable with known or suspected coronary disease * Patient referred to Caen University Hospital for a myocardial perfusion SPECT * Patient who accept to undergo subsequent additional cardiac dynamic SPECT using 99mTc-DTPA at rest and during pharmacological stress * Informed consent dated and signed * Affiliation to a social security system

Exclusion criteria

* Contraindication to dipyridamole (asthma, chronic obstructive pulmonary disease , pulmonary hypertension) * History of poor tolerance of dipyridamole injection * Cardiac arrhythmia (atrial fibrillation or frequent premature ventricular complex) * Left bundle branch block, cardiac pacemaker, or implantable automatic defibrillator * Recent history of myocardial infarction or unstable angina * Pregnancy or lactating women * Known obstructive renal or urinary disease * Age under 18 years or guardianship * Patient with an acute coronary syndrome or a coronary revascularization occurring between the conventional perfusion SPECT and the subsequent 99mTc-DTPA dynamic SPECT

Design outcomes

Primary

MeasureTime frame
Feasibility of myocardial flow reserve assessment by dynamic cardiac SPECT using a CZT camera and 99mTc-DTPAWithin one month after a conventional myocardial perfusion SPECT

Contacts

Primary ContactAlain Manrique, MD, PhD
manrique@cyceron.fr(+33) 231 470 287
Backup ContactDenis Agostini, MD, PhD
agostini-de@chu-caen.fr(+33) 231 063 246

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026